Author:
Gibbins Karen J.,Vora Neeta L.,Subramaniam Akila,Page Jessica M.,Riches Naomi O.,Rothwell Erin
Abstract
The cause of death in many stillbirths remains unexplained, in part because of systematic barriers to complete workup. We review the importance of placental pathology, fetal autopsy, and genetic testing in stillbirth workup. Placental pathology is useful in 65% of stillbirths, and fetal autopsy is useful in 42%. Currently, only 21% of stillbirths in the United States undergo autopsy. Barriers to complete stillbirth workup include cost of autopsy and genetic testing, availability of perinatal pathology expertise, health care professional knowledge about workup, and availability of skilled counseling to support bereaved parents in making decisions about autopsy and genetic workup. We propose solutions to overcome these barriers, including policy changes to expand access and a framework for high-quality patient counseling and decision support.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference48 articles.
1. Fetal mortality: United States, 2021;Gregory;Natl Vital Stat Rep,2023
2. Causes of death among stillbirths;JAMA,2011
3. Management of stillbirth. Obstetric Care Consensus No. 10 [published erratum appears in Obstet Gynecol 2023;141:1030]. American College of Obstetricians and Gynecologists;Obstet Gynecol,2020
4. Diagnostic tests for evaluation of stillbirth: results from the Stillbirth Collaborative Research Network;Page;Obstet Gynecol,2017
5. Fetal autopsy rates in the United States: analysis of National Vital Statistics;Oliver;Obstet Gynecol,2022